Bringing the Parkinson’s disease treatment to the next level

1
bringingParkinsons disease treatmentto the
next level
2
Parkinsons disease is a progressive neurological
disorder that affects the senses and hence, the
movements. Gradually develops with time,
sometimes it just starts with minor barely
noticeable tremors. But sadly, these minor
tremors are the most well-known signs of this
chronic neurodegenerative disorder that causes
slowing of the movement.
It has affected over 10 million people globally.
Symptoms of this neurological disorder appear
very late, mostly after the onset of the disease.
Men are more likely to develop Parkinsons
disease, mostly after the age of 50. If we
particularly talk about India, there is a large
population of senior citizens, susceptible to
this disorder.
3
symptoms

• No facial expression
• Depression and anxiety
• Drooling
• Hallucinations
• Slow blinking
• Difficulty in swallowing
• Tremors
• Loss of fine hand movements
• Memory loss
• Aches and pains
• Stooped posture
• Problems with balance while walking

4
Prevalence
Even after a lot of research and development for
the Parkinsons disease treatment, this
neurodegenerative disease is growing day by day.
If we see the most populous countries of world,
China has the highest number of patients with
this chronic disorder of the brain.
5
Prevalence
6
treatment
Scientists across the globe have done research
for the Parkinsons disease treatment and
developed some drugs to improve the condition.
However this neurological disorder cant be cured
completely, medications may just markedly improve
the patients symptoms.
7
La renons efforts
Were active in neurological disorders and ours
is the fastest-growing CNS segments of the
country. With more than 60 products in the
basket with more to be added, we cater to the
diseases as severe as stroke, Epilepsy,
Alzheimers, Parkinsons, Schizophrenia,
Neuropathic Pain, Major Depressive Disorder and
Borderline Personality Disorder.
8
medicines
We have developed Pexopram for Parkinsons
disease treatment which contains Pramipexole
Dihydrochloride. Available in 0.125 mg, 0.25 mg,
0.5 mg and 1.0 mg tablets, Pexopram is developed
after the in-depth clinical research. When added
to a stable anti-parkinsonian medication,
Pramipexole doesnt only work entirely as an
anti-parkinsonian agent with respect to
improvement in ADL or UPDRS motor scores but also
leads to a statistically considerable reduction
in parkinsonian tremors.
9
SOURCES

1. Wikipedia
2. Parkinson.org
3. LaRenon.com

10
To know more about the Parkinsons disease
treatment, Visit www.larenon.in